Those fundamentals come into play the moment we have another...

Those fundamentals come into play the moment we have another update towards the product launch.
In last week's shareholder update we were told that several negotiations are ongoing.
I see this as a slight delay, hardly worth selling ones shares with a loss.
The ones selling were the ones buying on speculation for the options to be in the money.

I find it fair to assume that the negotiations with other pharmacy chains are coming to a close this week, also providing a 3 week window which created ample time to get product into the pharmacies.
We do know that a marketing campaign is pending, therefore selling at 1 cents seems to me panic related


It all points towards a conclusive development, wether this to be positive or negative.
Circumstances do not allow this to stay neutral for much longer.